Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1. by Kasirye, P, Kendall, L, Adkison, K, Tumusiime, C, Ssenyonga, M, Bakeera-Kitaka, S, Nahirya-Ntege, P, Mhute, T, Kekitiinwa, A, Snowden, W, Burger, D, Gibb, D, Walker, A

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factori... by Kekitiinwa, A, Cook, A, Nathoo, K, Mugyenyi, P, Nahirya-Ntege, P, Bakeera-Kitaka, S, Thomason, M, Bwakura-Dangarembizi, M, Musiime, V, Munderi, P, Naidoo-James, B, Vhembo, T, Tumusiime, C, Katuramu, R, Crawley, J, Prendergast, A, Musoke, P, Walker, A, Gibb, D